| Liu, Wei |
NCT06288334: Exploration of the Optimal Dosage of Cetirizine in the Treatment of Allergic Diseases in Chinese Children |
|
|
| Recruiting | 4 | 80 | RoW | 1-3 Cetirizine Pharmacokinetic samples | Peking University Third Hospital | Allergic Disease, Children | 03/24 | 05/24 | | |
NCT02864953 / 2017-004854-41: Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction |
|
|
| Terminated | 3 | 535 | Europe, Canada, Japan, US, RoW | BIIB093, glibenclamide, glibenclamide intravenous (IV), glyburide, CIRARA, Placebo | Remedy Pharmaceuticals, Inc. | Brain Edema, Stroke, Acute | 08/23 | 08/23 | | |
| Active, not recruiting | 3 | 514 | US | Argatroban, Eptifibatide, Placebo | Washington University School of Medicine, National Institute of Neurological Disorders and Stroke (NINDS) | Acute Ischemic Stroke | 12/23 | 04/25 | | |
| Recruiting | 3 | 700 | US | Apixaban, Eliquis, Aspirin | Yale University, National Institute of Neurological Disorders and Stroke (NINDS) | Intracerebral Hemorrhage, Atrial Fibrillation | 04/27 | 04/27 | | |
TAPIS, NCT06316570: Ticagrelor With Aspirin Dual Antiplatelet Therapy Combined With Intravenous Thrombolysis for Ischemic Stroke |
|
|
| Recruiting | 3 | 1380 | RoW | Early Dual Antiplatelet Therapy, Ticagrelor and Aspirin, Placebo, Placebo of Ticagrelor and Aspirin | Beijing Tiantan Hospital | Ischemic Stroke, Acute | 12/25 | 12/26 | | |
| Active, not recruiting | 3 | 408 | RoW | KN046, placebo | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Advanced Pancreatic Ductal Adenocarcinoma | 04/24 | 08/24 | | |
NCT06434467: The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic Lymphoma |
|
|
| Not yet recruiting | 3 | 83 | RoW | Nelarabine injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | T-lymphoblastic Leukemia, T-lymphoblastic Lymphoma | 12/25 | 05/26 | | |
NCT05545137: Clinical Trial of Pivmecillinam Hydrochloride Tablets in the Treatment of Uncomplicated Urinary Tract Infection |
|
|
| Completed | 3 | 299 | RoW | Pivmecillinam hydrochloride tablets, Selexid®, Fosfomycin Tromethamine Granules, Monurol® | Benova (Tianjin) Innovative medicine Research Co., Ltd. | Uncomplicated Urinary Tract Infection | 02/24 | 02/24 | | |
| Completed | 2 | 3 | RoW | ICP-022 | Beijing InnoCare Pharma Tech Co., Ltd. | Diffuse Large B Cell Lymphoma | 11/21 | 12/21 | | |
NCT05346146: A Prospective, Single-arm, Exploratory Clinical Study of Sintilimab Injection in Combination With Paclitaxel (Albumin-bound) and Gemcitabine in Translational Therapy in Patients With Unresectable Locally Advanced Pancreatic Cancer. |
|
|
| Recruiting | 2 | 20 | RoW | Sintilimab; Gemcitabine; Albumin-paclitaxel | RenJi Hospital, Innovent Biologics (Suzhou) Co. Ltd. | Unresectable Locally Advanced Pancreatic Cancer | 07/23 | 07/24 | | |
NCT03837873: DLCL002 Protocol for Patients With High Risk Aggressive B-cell Lymphoma |
|
|
| Recruiting | 2 | 118 | RoW | Rituximab, Etoposide, Vincristine, Doxorubicin, Dexamethasone, Cyclophosphamide, Lenalidomide, Cisplatin, Cytarabine | Institute of Hematology & Blood Diseases Hospital | Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Transformed Lymphoma | 09/23 | 09/24 | | |
NCT06244368: GVM±R in Patients With Relapsed or Refractory Aggressive NHL. |
|
|
| Recruiting | 2 | 115 | RoW | GVM±R regimen | Qiu Lugui | Peripheral T Cell Lymphoma, Diffuse Large B-cell Lymphoma | 06/25 | 06/27 | | |
| Recruiting | 2 | 120 | RoW | Etoposide, Cyclophosphamide, Mecapegfilgrastim, day 2, Mecapegfilgrastim, day 5 | Qiu Lugui, Jiangsu Hengrui Pharmaceuticals Co.,Ltd | Multiple Myeloma, Lymphoma | 03/24 | 09/24 | | |
NCT06489808: Linperlisib Combined With Immunochemotherapy in Relapsed/Refractory LBCL |
|
|
| Recruiting | 2 | 89 | RoW | Linperlisib, Rituximab, Gemcitabine, Oxaliplatin, Ifosfamide, Carboplatin, Etoposide, Dexamethasone, Cisplatin, Ara-C, Vinorelbine, Mitoxantrone hydrochloride liposome | Institute of Hematology & Blood Diseases Hospital, China | Relapsed/Refractory Large B-Cell Lymphoma | 12/26 | 05/27 | | |
NCT05997602: To Evaluate the Efficacy, Safety, and PK Characteristics of FCN-159 in Pediatric Patients With Refractory/Recurrent LCH |
|
|
| Recruiting | 2 | 56 | RoW | FCN-159 | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | Langerhans Cell Histiocytosis, LCH | 07/24 | 07/26 | | |
NCT04690192: CNCT19 Following ASCT in Patients With Relapsed or Refractory B-cell Lymphoma |
|
|
| Active, not recruiting | 1/2 | 20 | RoW | CNCT19, Gemcitabine Injection, busulfan, Melphalan Injection | Zou Dehui, Juventas Cell Therapy Ltd. | Large B-cell Lymphoma | 12/23 | 12/24 | | |
NCT06594640: R-CMOP in Patients with Newly Diagnosed Diffuse Large B-cell Lymphoma |
|
|
| Recruiting | 1/2 | 108 | RoW | Mitoxantrone Hydrochloride Liposome, Rituximab (R), Cyclophosphamide (CTX), Vincristin, Prednisolone | Qiu Lugui | Diffuse Large B-cell Lymphoma | 06/26 | 07/27 | | |
NCT04464551: The Absorption, Metabolism and Excretion of [14C]D-0316 in Human |
|
|
| Active, not recruiting | 1 | 4 | RoW | [14C]D-0316 suspension | Betta Pharmaceuticals Co., Ltd. | Advanced or Metastatic Non-small Cell Lung | 08/21 | 08/21 | | |
NCT04696705: Allogeneic γδ T Cells Immunotherapy in r/r Non-Hodgkin's Lymphoma (NHL) or Peripheral T Cell Lymphomas (PTCL) Patients |
|
|
| Recruiting | 1 | 10 | RoW | Ex-vivo expanded allogeneic γδT cells | Institute of Hematology & Blood Diseases Hospital, Beijing GD Initiative Cell Therapy Technology Co., Ltd., Chinese Academy of Medical Sciences | Non-Hodgkin's Lymphoma (NHL), Peripheral T Cell Lymphoma (PTCL) | 12/21 | 12/23 | | |
| Active, not recruiting | 1 | 18 | RoW | Liposomal Mitoxantrone Hydrochloride dose level 1, Liposomal Mitoxantrone Hydrochloride dose level 2, Liposomal Mitoxantrone Hydrochloride dose level 3, Liposomal Mitoxantrone Hydrochloride dose level 4 | Institute of Hematology & Blood Diseases Hospital, China, CSPC Ouyi Pharmaceutical Co., Ltd. | Non Hodgkin Lymphoma | 12/23 | 12/25 | | |
NCT05318963: Targeting CD19/CD20/CD22 Triple-targeted Cell in Patients With Relapsed/Refractory B-cell Lymphoma |
|
|
| Recruiting | 1 | 34 | RoW | LCAR-AIO cells product | Qiu Lugui, Nanjing Legend Biotech Co. | B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory | 06/24 | 06/26 | | |
| Recruiting | N/A | 80 | RoW | Ursodeoxycholic Acid 250 Mg Oral Capsule | Wei Liu | Cholestasis of Parenteral Nutrition | 09/21 | 07/22 | | |
NCT04307030: Study on AI Recognition System Of Heart Sound In Congenital Heart Disease Screening |
|
|
| Recruiting | N/A | 5000 | RoW | Heart Auscultation and Echocardiography | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Congenital Heart Disease in Children | 12/21 | 06/23 | | |
PLAND, NCT03498885: Comparison of Low and High Ligation With Apical Lymph Node Dissection in the Laparoscopy Rectal Cancer |
|
|
| Recruiting | N/A | 466 | RoW | Low ligation, LL, High ligation, HL | WEIDONG LIU，MD | Rectal Cancer | 12/22 | 12/25 | | |
NCT04853238: Chronic Obstructive Pulmonary Disease (COPD) Maintenance Treatment Patterns in China |
|
|
| Completed | N/A | 1507 | RoW | Prospective observational cohort study | GlaxoSmithKline | Pulmonary Disease, Chronic Obstructive | 11/22 | 02/23 | | |
NCT03621631: Effect of Tai Chi Exercise on Mechanical Joint Loading in Knee Osteoarthritis |
|
|
| Recruiting | N/A | 60 | US | Optimized Tai Chi intervention, OTC, Traditional Tai Chi intervention, TTC | Edward Via Virginia College of Osteopathic Medicine, National Center for Complementary and Integrative Health (NCCIH), The University of Texas Health Science Center at San Antonio | Knee Osteoarthritis | 07/23 | 09/23 | | |
NCT02515474: Comparison of LCBDE vs ERCP + LC for Choledocholithiasis |
|
|
| Completed | N/A | 1000 | RoW | Laparoscopy, Laparoscopic common bile duct exploration (LCBDE), Endoscopy, Endoscopic Retrograde cholangiopancreatography (ERCP) | Hepatopancreatobiliary Surgery Institute of Gansu Province | Choledocholithiasis | 01/24 | 01/24 | | |
NCT06249087: Multifunctional Nutrition Tube on Social Condition and Experience in Cerebralvascular Accident |
|
|
| Recruiting | N/A | 80 | RoW | comprehensive rehabilitation therapy, Intermittent Oro-esophageal Tube Feeding, Nasogastric Tube Feeding | Zeng Changhao | Stroke | 05/24 | 05/24 | | |
NCT06255730: The Effect of Stellate Ganglion Block on Insomnia Patients |
|
|
| Recruiting | N/A | 50 | RoW | Stellate Ganglion Block, Lidocaine Hydrochloride | Zeng Changhao | Insomnia | 06/24 | 06/24 | | |
| Recruiting | N/A | 100 | RoW | systemic therapy, Intermittent Oro-Esophageal Tube Feeding, Persistent Nasogastric Tube Feeding | Zeng Changhao | Cerebral Palsy | 12/24 | 12/24 | | |
NCT06255353: Effect of Different Feeding Modes in Intracerebral Hemorrhage |
|
|
| Recruiting | N/A | 120 | RoW | Intermittent Oro-esophageal Tube Feeding, Basic treatment, Nasogastric Tube Feeding | Zeng Changhao | Intracerebral Hemorrhage | 06/24 | 06/24 | | |
IOE+JLCJ-S, NCT06265779: Transcranial Direct Current Stimulation Combined With Intermittent Oral to Esophageal Tube on Dysphagia |
|
|
| Recruiting | N/A | 84 | RoW | Comprehensive rehabilitation therapy, Intermittent Oro-esophageal Tube Feeding, Transcranial direct current stimulation | Zeng Changhao, The First Affiliated Hospital of Zhengzhou University | Cerebral Infarction | 11/24 | 12/24 | | |
ABE-S, NCT06265818: The Effect of Active Breathing Exercises in Stroke Patients With Respiratory Rhythm Disorder |
|
|
| Recruiting | N/A | 80 | RoW | Rehabilitation training, Active Breathing Exercises | Zeng Changhao, The First Affiliated Hospital of Zhengzhou University | Respiratory Rhythm Disorder | 05/24 | 05/24 | | |
| Not yet recruiting | N/A | 500 | RoW | Assessment of plaque morphology, structure, and stability in non-culprit lesions | Chinese PLA General Hospital | Coronary Arterial Disease (CAD), Acute Coronary Syndromes | 12/27 | 12/31 | | |
NCT05649488: Evaluate the Safety and Efficacy of Intracoronary Lithotripsy Balloon Catheter and Intracoronary Lithotripsy Apparatus |
|
|
| Recruiting | N/A | 184 | RoW | Intracoronary lithotripsy balloon catheter and Intracoronary lithotripsy apparatus, Dragonfly Opstar Imaging Catheter | Shanghai Bluesail Boyuan Medical Technology Co., Ltd. | Coronary Artery Disease, Intravascular Lithotripsy | 12/24 | 09/25 | | |
NCT05449106: Evaluation of Clinical Outcomes of Unruptured bAVMs Treated With Medical Management Alone Based on Multimodal CT |
|
|
| Recruiting | N/A | 200 | RoW | | Beijing Tiantan Hospital, Beijing Hospital, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, The First Affiliated Hospital of Zhengzhou University | Brain Arteriovenous Malformations | 05/27 | 05/32 | | |
NCT04805853: Myocardial Pathological Changes in Patients of Type 2 Diabetes With or Without PCOS Using Cardiac Magnetic Resonance |
|
|
| Recruiting | N/A | 561 | RoW | | RenJi Hospital | Type2 Diabetes, Polycystic Ovary Syndrome | 02/22 | 02/22 | | |
NCT05463627: Effects of Metformin on Metabolic and Reproductive Outcomes in Chinese PCOS Patients |
|
|
| Recruiting | N/A | 1440 | RoW | Metformin, melbine | RenJi Hospital | Polycystic Ovary Syndrome, Metformin | 01/23 | 01/23 | | |
NCT04830826: A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China |
|
|
| Recruiting | N/A | 2000 | RoW | Surgeries | The First Affiliated Hospital of Guangzhou Medical University | NSCLC, Stage I, NSCLC, Stage II, NSCLC, Stage III | 01/24 | 07/24 | | |
| Shao, Feng |
NCT04464551: The Absorption, Metabolism and Excretion of [14C]D-0316 in Human |
|
|
| Active, not recruiting | 1 | 4 | RoW | [14C]D-0316 suspension | Betta Pharmaceuticals Co., Ltd. | Advanced or Metastatic Non-small Cell Lung | 08/21 | 08/21 | | |
NCT05125211: Safety,Tolerability,and Pharmacokinetics Profiles of GB001 Recombinant Peptide Spray in Healthy Subjects |
|
|
| Active, not recruiting | 1 | 91 | RoW | GB001 recombinant peptide spray, Placebo | Zhejiang Echon Biopharm Limited | Healthy | 11/24 | 05/25 | | |
NCT06467851: Effect of Suanzaoren Decoction and Huanglian Wendan Decoction on Biorhythm of Insomnia Patients |
|
|
| Completed | N/A | 19 | RoW | Suanzaoren Decoction and Huanglian Wenda Decoction | The First Affiliated Hospital with Nanjing Medical University | Chronic Insomnia, Melatonin, Circadian Rhythm, Suanzaoren Decoction and Huanglian Wendan | 04/24 | 04/24 | | |
| Professor, Feng Shao，Associate |
| No trials found |
